Žå—v˜_•¶
œ Okamoto C, Hayakawa Y,
Aoyama T, Komaki H, Minatoguchi S, Iwasa M, Yamada Y, Kanamori H, Kawasaki M, Nishigaki
K, Mikami A, Minatoguchi S. Excessively low salt diet damages the heart
through activation of cardiac (pro) renin receptor, renin-angiotensin-aldosterone,
and sympatho-adrenal systems in spontaneously hypertensive rats. PLoS One.
12(12):e0189099. 2017.
œYokoyama C,
Aoyama T, Ido T, Kakino A, Shiraki T, Tanaka T, Nishigaki K, Hasegawa A, Fujita
Y, Sawamura T, Minatoguchi S. Deletion of LOX-1 Protects against Heart
Failure Induced by Doxorubicin. PLoS One. 11(5):e0154994. 2016 (Ó”C’˜ŽÒ)
œHayakawa Y,
Aoyama T, Yokoyama C, Okamoto C, Komaki H, Minatoguchi S, Iwasa M, Yamada Y, Kawamura I, Kawasaki M, Nishigaki K, Mikami A, Suzuki F, Minatoguchi S. High salt intake damages the heart through activation of cardiac (pro) renin receptors even at an early stage of hypertension. PLoS One. 10(3):e0120453. 2015.
œShiraki T,
Aoyama T, Yokoyama C, Hayakawa Y, Tanaka T, Nishigaki K, Sawamura T, Minatoguchi
S. LOX-1 plays an important role in ischemia-induced angiogenesis of limbs.
PLoS One. 9(12):e114542. 2014. (Ó”C’˜ŽÒ)
œTakahashi S, Kawasaki M, Miyata S, Suzuki K, Yamaura M, Ido T,
Aoyama T, Fujiwara H, Minatoguchi S. Feasibility of tissue characterization of
coronary plaques using 320-detector row computed tomography: comparison
with integrated backscatter intravascular ultrasound. Heart Vessels. 31(1):29-37.
2014
œHattori A, Kawamura I, Yamada Y, Kanamori H,
Aoyama T, Ushikoshi H, Kawasaki M, Nishigaki K, Tamemura G, Minatoguchi S. Elevated
plasma GLP-1 levels and enhanced expression of cardiac GLP-1 receptors
as markers of left ventricular systolic dysfunction: a cross-sectional
study. BMJ Open. 3(9):e003201. 2013
œMinatoguchi S,
Aoyama T, Kawai N, Iwasa M, Oda M, Kida K, Kojima S, Goto N, Goto M, Sugishita F, Takai K, Tanaka R, Hiei K, Minagawa T, Yamamoto N, Watanabe I, Yasue T, Kobayashi H. Comparative effect of candesartan and amlodipine, and effect of switching from valsartan, losartan, telmisartan and olmesartan to candesartan, on early morning hypertension and heart rate. Blood Press.:29-37. 2013
œYamada Y, Kobayashi H, Iwasa M, Sumi S, Ushikoshi H,
Aoyama T, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Kiso M, Minatoguchi
S. Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes
with sialyl Lewis X repairs infarcted myocardium in rabbits. Am J Physiol
Heart Circ Physiol. 304(8):H1124-33. 2013
œIwasa M, Yamada Y, Kobayashi H, Yasuda S, Kawamura I, Sumi S, Shiraki
T, Yamaki T, Ushikoshi H, Hattori A,
Aoyama T, Nishigaki K, Takemura G, Fujiwara H, Minatoguchi S. Both stimulation
of GLP-1 receptors and inhibition of glycogenolysis additively contribute
to a protective effect of oral miglitol against ischaemia-reperfusion injury
in rabbits. Br J Pharmacol. 164(1):119-31. 201
œKawamura I, Takemura G, Kanamori H, Takeyama T, Kawaguchi T, Tsujimoto
A, Goto K, Maruyama R, Watanabe T, Shiraki T,
Aoyama T, Fujiwara T, Fujiwara H, Minatoguchi S. Repeated phlebotomy augments angiogenesis
to improve blood flow in murine ischemic legs. Am J Physiol Heart Circ
Physiol. H372-8. 201
0
œ
Aoyama T, Matsui T, Novikov M, Park J, Hemmings B, Rosenzweig A. Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation. 111(13):1652-9. 2005 i•M“ª’˜ŽÒj
œNagoshi T, Matsui T,
Aoyama T, Leri A, Anversa P, Li L, Ogawa W, del Monte F, Gwathmey JK, Grazette
L, Hemmings B, Kass DA, Champion HC, Rosenzweig A. PI3K rescues the detrimental
effects of chronic Akt activation in the heart during ischemia/reperfusion
injury. J Clin Invest. 115(8):2128-38. 2005
œ
Aoyama T, Takemura G, Maruyama R, Kosai K, Takahashi T, Koda M, Hayakawa K, Kawase
Y, Minatoguchi S, Fujiwara H. Molecular mechanisms of non-apoptosis by
Fas stimulation alone versus apoptosis with an additional actinomycin D
in cultured cardiomyocytes. Cardiovasc Res. 55(4):787-98. 2002 i•M“ª’˜ŽÒj
œ
Aoyama T. Chen, M. Fujiwara, H Masaki, T. Sawamura, T. LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells. FEBS Lett 467: 217-20. 2000 i•M“ª’˜ŽÒj
œ
Aoyama T. Fujiwara, H. Masaki, T. Sawamura, T. Induction of lectin-like oxidized
LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial
cells. J Mol Cell Cardiol 31: 2101-14. 1999 i•M“ª’˜ŽÒj
œ
Aoyama T. Sawamura, T. Furutani, Y. Matsuoka, R. Yoshida, M. C. Fujiwara, H. Masaki,
T. Structure and chromosomal assignment of the human lectin-like oxidized
low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem J 339: 177-84.
1999 i•M“ª’˜ŽÒj
œKanoh, M. Takemura, G. Misao, J. Hayakawa, Y.
Aoyama T. Nishigaki, K. Noda, T. Fujiwara, T. Fukuda, K. Minatoguchi, S. Fujiwara, H. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation. 99: 2757-64. 1999
œMoriwaki, H. Kume, N. Sawamura, T. Aoyama T. Hoshikawa, H. Ochi, H. Nishi,
E. Masaki, T. Kita, T. Ligand specificity of LOX-1, a novel endothelial
receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc
Biol 18: 1541-7. 1998
œKume, N. Murase, T. Moriwaki, H. Aoyama T. Sawamura, T. Masaki, T. Kita,
T. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular
endothelial cells. Circ Res 83: 322-7. 1998
œSawamura, T. Kume, N. Aoyama T. Moriwaki, H. Hoshikawa, H. Aiba, Y. Tanaka,
T. Miwa, S. Katsura, Y. Kita, T. Masaki, T. An endothelial receptor for
oxidized low-density lipoprotein. Nature 386: 73-7. 199